The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): Outcomes in patients (pts) with baseline (BL) thrombocytopenia.
 
Claire N. Harrison
Honoraria - CTI; Gilead Sciences; Novartis; Sanofi
Consulting or Advisory Role - CTI
Speakers' Bureau - CTI; Novartis; Sanofi; Shire
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Miklos Egyed
No Relationships to Disclose
 
Anita Szoke
No Relationships to Disclose
 
Aleksandr Suvorov
No Relationships to Disclose
 
Andrew Perkins
No Relationships to Disclose
 
Jiri Mayer
Research Funding - Cell Therapeutics
 
Peter Ganly
No Relationships to Disclose
 
Harry C. Schouten
No Relationships to Disclose
 
Patrizia Tosi
No Relationships to Disclose
 
Charles Michael Farber
Stock and Other Ownership Interests - Alexion Pharmaceuticals
Honoraria - Janssen
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene; Genentech; Gilead Sciences; Janssen
Research Funding - Celgene
 
Pierre Zachee
No Relationships to Disclose
 
Christof Scheid
Honoraria - AMGEN; Baxalta; Celgene; Janssen; Novartis; Pfizer
Consulting or Advisory Role - AMGEN; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Pfizer
Research Funding - Novartis
 
James P. Dean
Employment - CTI
Stock and Other Ownership Interests - CTI
 
Huafeng Zhou
Employment - CTI
Stock and Other Ownership Interests - CTI
 
Jean-Jacques Kiladjian
Research Funding - Novartis
 
Alessandro M. Vannucchi
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis; Shire
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; Shire
 
Jyoti Nangalia
No Relationships to Disclose
 
Adam Mead
Honoraria - ARIAD; Baxalta; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - ARIAD; Baxalta; Bristol-Myers Squibb; Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Ruben A. Mesa
Honoraria - AOP Orphan Pharmaceuticals; Novartis; shire
Consulting or Advisory Role - Baxalta; Galena Biopharma
Research Funding - CTI (Inst); Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); NS Pharma (Inst); Pfizer (Inst); Pharmaessentia (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - AOP Orphan Pharmaceuticals; Incyte; Novartis